70095-130 : Unloxcyt 300 mg/5ml Intravenous Injection, Solution
| NDC: | 70095-130 |
| Labeler: | Sun Pharmaceutical Industries, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Unloxcyt |
| Dosage Form: | Intravenous Injection, Solution |
| Application #: | BLA761297 |
| Rev. Date: |
NDC Package Codes:
- 70095-130-01: 1 VIAL, GLASS IN 1 CARTON (70095‑130‑01) / 5 ML IN 1 VIAL, GLASS
Active Ingredients:
- Cosibelimab
Dosage Strength:
- 300 mg/5mL
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- Programmed Death Ligand-1 Antagonists [MoA]
- Programmed Death Ligand-1 Blocker [EPC]
- Programmed Death Ligand-1-directed Antibody Interactions [MoA]
Related Products:
Based on records with the same trade name.- 83444-301 Unloxcyt 300 mg/5ml Intravenous Injection, Solution by Checkpoint Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70095-080Next: 70096-001 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.